Société à responsabilité limitée Route de Bastogne Parts détenues Nombre 131 000 Administrateur(s) / Gérant(s) Régime de signature statutaire Sous réserve de la Loi Luxembourgeoise et des présents Statuts, la Société est valablement engagée ou représentée à l'égard des tiers par : 10.1 si la Société a un Gérant Unique, la seule signature du Gérant Unique; 10.2 si la Société a plus d'un (1) Gérant, la signature unique de tout Gérant, à condition cependant que si des catégories différentes de Gérants (à savoir Gérant de catégorie A et Gérant de catégorie B) sont nommés, également la signature unique de tout Gérant (y compris par le biais de la représentation); 10.3 la signature unique de toute personne à qui un tel pouvoir aura été délégué conformément à l'Article 11. Palm Christoph Page 4 / 5 Délégué à la gestion journalière Pouvoir de signature La Société est valablement engagée et représentée à l'égard de tiers pour tout ce qui relève de la gestion journalière par la signature individuelle du délégué à la gestion journalière dans les limites des pouvoirs qui lui ont été délégués par décision du conseil de gérance. 05/07/2018 Personne(s) chargée(s) du contrôle des comptes ERNST & YOUNG [2] ERNST & YOUNG N° d'immatriculation au RCS B47771 ERNST & YOUNG Société anonyme 35E Avenue John F. Le gestionnaire du registre de commerce et des sociétés ne garantit l'authenticité de l'origine et l'intégrité des informations contenues sur le présent extrait par rapport aux informations inscrites au registre de commerce et des sociétés que si le présent extrait comporte une signature électronique émise par le gestionnaire du registre de commerce et des sociétés. 2021-11-16T13:12:39+0000

Figure 11. Figure 11. The most common color concentrate carrier is PP because it is compatible with many commercially available TPE products (for both single component molding and overmolding PP applications).

DIFAS T O O T H B R U S H H A N D L E • Replace current polymer with a more sustainable solution • Excellent surface finish with multiple color options • Processed using current molding equipment and machinery • Used formulation expertise to develop a custom formulation that met critical quality parameters and enabled customer to use existing molding equipment • Enabled customer to work towards sustainability goals and bring a competitive solution to the market • Enhanced the marketplace appeal of the end product with colorability of the material Maxxam BIO Bio-based Polyolefin Formulations KEY REQUIREMENTS WHY AVIENT? AVIENT SOLUTION SUSTAINABILITY + AESTHETIC LEARN MORE © 2024, Avient Corporation, All Rights Reserved https://www.avient.com/products/engineered-polymer-formulations/sustainable-formulations/maxxam-bio-bio-based-polyolefin-formulations DIFAS

NYSE: AVNT) AVIENT CORPORATION I N V E S T O R M E E T I N G S M AY 2 0 2 2 DISCLAIMER Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Source: Peer data per Bloomberg market data as of April 21, 2022 86 82 86 86 84 78 77 89 86 81 80 76 76 76 67 67 11 (12) P PM AV VR 18% 16% 15% 15% 14% 14% 28% 28% 26% 22% 21% 19% 9% 9% T od ay P AV PM C VR Median: 21%Median: 15% 2022 EBITDA MARGINS VS. Financials are pro forma for the acquisition of Dyneema® and potential divestiture of Distribution Avient Specialty Other Specialty / Chemical Companies 45 Source: Peer data per Bloomberg market data as of April 21, 2022 Total Enterprise Value / NTM EBITDA With the Dyneema and Clariant Color business acquisition and divestment of the PP&S business, along with the proposed sale of our Distribution business, our exposure is now concentrated in less-cyclical and high-growth markets.

Hammerhead™ FR Flame Retardant Composite Panels Hammerhead™ FR Flame Retardant Composite Panels Maxxam™ NHFR Non-Halogen Flame Retardant Polyolefins

Hammerhead™ FR Flame Retardant Composite Panels Hammerhead™ FR Flame Retardant Composite Panels Maxxam™ NHFR Non-Halogen Flame Retardant Polyolefins

Hammerhead™ FR Flame Retardant Composite Panels Hammerhead™ FR Flame Retardant Composite Panels Maxxam™ NHFR Non-Halogen Flame Retardant Polyolefins

It’s why we win. 11 474 644 924 107 147 208 467 616 872 2014 2018 2020PF R&D / Technical Marketing Sales Commercial Resources + 36% + 37% + 32% + 43% + 41% + 42% Headcount figures are Pro forma for the sale of Designed Structures and Solutions (DSS) and Performance Products and Solutions (PP&S) segments and the acquisition of the Clariant Masterbatch business. 2020PF data as of August 31, 2020. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 21 1. Avient Total Enterprise Value Pro forma for acquisition of Clariant Masterbatch business and tax payments associated with the PP&S divestiture per Company filings, resulting in a cash adjustment from the June 30, 2020 balance sheet of ~$1,520MM 2.

Microsoft PowerPoint - Avient Q1 2021 Earnings - Final (For Print) AVIENT CORPORATION F I R S T Q U A R T E R 2 0 2 1 R E S U LT S (NYSE: AVNT) A P R I L 3 0 , 2 0 2 1 DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. This innovation drives performance and is reflective of consistent, strategic investments in our portfolio…and people. 2020 Pro forma $991 $86 Sustainable Solutions 15 11% 6 Healthcare 28 22% 6 Composites 6 10% 3 Growth in Emerging Regions 44 30% 10 Other 53 10% 7 Sub-total $1,137 15% $118 FX Impact 25 - 2 Synergies - - 11 Incentives, Travel, Other Employee Costs - - (8) 2021 Actual $1,162 17% $123 Q1 2021 ORGANIC SALES AND OPERATING INCOME 7 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Sales Growth Rate Operating Income$ millions 8 Wire & Cable Transportation Industrial Healthcare Packaging Consumer Q1 2020PF Q1 2021 (2) Financial information is presented on a constant currency basis (1,2) (42% of total revenue) (58% of total revenue) Q1 END MARKET SALES PERFORMANCE +17% +14% +8% +10% +8% +22% +5% +24% Q 2 AN D FU LL Y EA R 2021 O U TLO O K $69 $112 $0.42 $0.80 ORGANIC GROWTH PROJECTIONS – Q2 10 Sales Adjusted Operating Income $870 $1,100 + 26% + 62% + 90% (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition FULL YEAR GUIDANCE INCREASED 11 Sales Adj. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 20 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Other 10.2 17.7 16.0 14.9 14.6 11.6 11.1 26.7 24.0 22.8 14.3 12.7 11.5 11.2 11.1 11.0 10.3 10.1 9.5 9.4 8.3 7.0 Median: 11.1xMedian: 14.8x SUMMARY: WHY INVEST IN AVIENT?

Use of Non-GAAP Measures Page 3 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • 18 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Continue specialty transformation • Targeting $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% 450.00% PolyOne S&P 500 Russell 2000 Dow Jones Chemical All time high of $39.28 April 4th, 2014 • 18 consecutive quarters of double digit EPS growth • 49% CAGR adjusted EPS expansion 2006-2013 • 2013 stock price increased 73% versus 30% growth in the S&P • More than seven fold increase in market cap: $0.5b $3.6b Strategy and Execution Drive Results Page 6 Appliance 4% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 5% Consumer 10%Packaging 16% Industrial 12% HealthCare 11% Transportation 18% Misc. 2% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 1.31 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010 2011 2012 2013 2015 Target Ad ju st ed E ar ni ng s P er S ha re 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion EPS Page 7 PolyOne At A Glance United States 67% Europe 14% Canada 7% Asia 6% Latin America 6% Specialty 54% PP&S 18% Distribution 28% Mix Shift Highlights Specialty Transformation Page 8 Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 64% 0% 20% 40% 80% 2005 2008 2010 2013 Q1 2014 2015 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty 65-75% Specialty OI $5M $46M $87M $195M $60M Target 2015 Target Proof of Performance & 2015 Goals Page 9 2006 Q1 2014 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 13.8% 12 – 16% Global Specialty Engineered Materials 1.1% 11.6% 12 – 16% Designed Structures & Solutions -- 6.5% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 64% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 42% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid single digit revenue CAGR Innovation Drives Earnings Growth $20.3 $52.3 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years Page 11 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 42.0% 2006 Q1 2014 Healthcare Consumer Packaging and Additive Technology Transportation Page 12 Unique and Innovative Solutions https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of March 31, 2014 Debt Maturities & Pension Funding – 3/31/14 Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2014 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend  Expanding our sales, marketing, and technical capabilities  Investing in operational and initiatives that drive profitability growth Manufacturing realignment  Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.4 million shares in Q1 2014  Repurchased 6.4 million shares since April 2013  13.6 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?